Jump to content

Extracellular signal-regulated kinases

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Citation bot (talk | contribs) at 13:05, 19 February 2011 (Citations: [251]Tweaked: doi. User-activated.). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

In molecular biology, extracellular-signal-regulated kinases (ERKs) or classical MAP kinases are widely expressed protein kinase intracellular signalling molecules that are involved in functions including the regulation of meiosis, mitosis, and postmitotic functions in differentiated cells. Many different stimuli, including growth factors, cytokines, virus infection, ligands for heterotrimeric G protein-coupled receptors, transforming agents, and carcinogens, activate the ERK pathway.[citation needed]

The term, "extracellular-signal-regulated kinases", is sometimes used as a synonym for mitogen-activated protein kinase (MAPK), but has more recently been adopted for a specific subset of the mammalian MAPK family. In the MAPK/ERK pathway, Ras activates c-Raf, followed by mitogen-activated protein kinase kinase (abbreviated as MKK, MEK, or MAP2K) and then MAPK1/2 (below). Ras is typically activated by growth hormones through receptor tyrosine kinases and GRB2/SOS, but may also receive other signals. ERKs are known to activate many transcription factors, such as ELK1,[1] and some downstream protein kinases. Disruption of the ERK pathway is common in cancers, especially Ras, c-Raf and receptors such as HER2.

Mitogen-activated protein kinase 1

mitogen-activated protein kinase 1
Identifiers
SymbolMAPK1
Alt. symbolsPRKM2, PRKM1
NCBI gene5594
HGNC6871
OMIM176948
RefSeqNM_002745
UniProtP28482
Other data
LocusChr. 22 q11.2
Search for
StructuresSwiss-model
DomainsInterPro

Mitogen-activated protein kinase 1 (MAPK1) is also known as "extracellular signal-regulated kinase 2" (ERK2). Two similar (85% sequence identity) protein kinases were originally called ERK1 and ERK2.[2] They were found during a search for protein kinases that are rapidly phosphorylated after activation of cell surface tyrosine kinases such as the epidermal growth factor receptor. Phosphorylation of ERKs leads to the activation of their kinase activity.

The molecular events linking cell surface receptors to activation of ERKs are complex. It was found that Ras GTP-binding proteins are involved in the activation of ERKs.[3] Another protein kinase, Raf-1, was shown to phosphorylate a "MAPK kinase", thus qualifying as a "MAPK kinase kinase".[4] The MAPK kinase was named "MAPK/ERK kinase" (MEK).[5]

Receptor-linked tyrosine kinases, Ras, Raf, MEK, and MAPK could be fitted into a signaling cascade linking an extracellular signal to MAPK activation.[6] See: MAPK/ERK pathway.

Transgenic gene knockout mice lacking MAPK1 have major defects in early development.[7]

Mitogen-activated protein kinase 3

mitogen-activated protein kinase 3
Identifiers
SymbolMAPK3
Alt. symbolsPRKM3
NCBI gene5595
HGNC6877
OMIM601795
RefSeqNM_001040056
UniProtP27361
Other data
LocusChr. 16 p11.2
Search for
StructuresSwiss-model
DomainsInterPro

Mitogen-activated protein kinase 3 (MAPK3) is also known as "extracellular signal-regulated kinase 1" (ERK1). Transgenic gene knockout mice lacking MAPK3 are viable and it is thought that MAPK1 can fulfill most MAPK3 functions in most cells.[8] The main exception is in T cells. Mice lacking MAPK3 have reduced T cell development past the CD4+CD8+ stage.

References

  1. ^ Rao VN, Reddy ES (1994). "elk-1 proteins interact with MAP kinases". Oncogene. 9 (7): 1855–60. PMID 8208531. {{cite journal}}: Unknown parameter |month= ignored (help)
  2. ^ Boulton TG, Cobb MH (1991). "Identification of multiple extracellular signal-regulated kinases (ERKs) with antipeptide antibodies". Cell Regul. 2 (5): 357–71. PMC 361802. PMID 1654126. {{cite journal}}: Unknown parameter |month= ignored (help)
  3. ^ Leevers SJ, Marshall CJ (1992). "Activation of extracellular signal-regulated kinase, ERK2, by p21ras oncoprotein". EMBO J. 11 (2): 569–74. PMC 556488. PMID 1371463. {{cite journal}}: Unknown parameter |month= ignored (help)
  4. ^ Kyriakis JM, App H, Zhang XF; et al. (1992). "Raf-1 activates MAP kinase-kinase". Nature. 358 (6385): 417–21. doi:10.1038/358417a0. PMID 1322500. {{cite journal}}: Explicit use of et al. in: |author= (help); Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  5. ^ Crews CM, Erikson RL (1992). "Purification of a murine protein-tyrosine/threonine kinase that phosphorylates and activates the Erk-1 gene product: relationship to the fission yeast byr1 gene product". Proc. Natl. Acad. Sci. U.S.A. 89 (17): 8205–9. doi:10.1073/pnas.89.17.8205. PMC 49886. PMID 1381507. {{cite journal}}: Unknown parameter |month= ignored (help)
  6. ^ Itoh T, Kaibuchi K, Masuda T; et al. (1993). "A protein factor for ras p21-dependent activation of mitogen-activated protein (MAP) kinase through MAP kinase kinase". Proc. Natl. Acad. Sci. U.S.A. 90 (3): 975–9. doi:10.1073/pnas.90.3.975. PMC 45793. PMID 8381539. {{cite journal}}: Explicit use of et al. in: |author= (help); Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  7. ^ Yao Y, Li W, Wu J; et al. (2003). "Extracellular signal-regulated kinase 2 is necessary for mesoderm differentiation". Proc. Natl. Acad. Sci. U.S.A. 100 (22): 12759–64. doi:10.1073/pnas.2134254100. PMC 240691. PMID 14566055. {{cite journal}}: Explicit use of et al. in: |author= (help); Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  8. ^ Pagès G, Guérin S, Grall D; et al. (1999). "Defective thymocyte maturation in p44 MAP kinase (Erk 1) knockout mice". Science. 286 (5443): 1374–7. doi:10.1126/science.286.5443.1374. PMID 10558995. {{cite journal}}: Explicit use of et al. in: |author= (help); Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)